Evidence map›Paper›PMID 35915598›Full record

ArticleScientific African2022

Explainable features responsible for the high or low spread of SARS-CoV-2: Africa in view.

Olalekan J Akintande, Olusanya E Olubusoye, OlaOluwa S Yaya, Adeyinka O Abiodun

Abstract read
In one paragraph

Article in Scientific African, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Olalekan J AkintandeDepartment of Statistics, Laboratory for Interdisciplinary Statistical Analysis, Computational Unit, University of Ibadan, Nigeria.
Olusanya E OlubusoyeDepartment of Statistics, Laboratory for Interdisciplinary Statistical Analysis, Computational Unit, University of Ibadan, Nigeria.
OlaOluwa S YayaDepartment of Statistics, Laboratory for Interdisciplinary Statistical Analysis, Computational Unit, University of Ibadan, Nigeria.
Adeyinka O AbiodunAfrica Center of Excellence on Technology Enhanced Learning, National Open University of Nigeria, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The low spread of the global pandemic in Africa has raised concerns. Consequently, many commentators have misconstrued concerns suspecting weather, and immunity to be prime reasons. This study investigates the factors associated with the high and low spread of the SARS-CoV-2 (also known as COVID-19) and employs graphical Bayesian models to investigate feature interactions and causality. Through experimentation with the Bayesian framework, we propose that: (i) the proportion of people within the country population who test positive for SARS-CoV-2 and a country's test capacity cause the rate of spread of the virus [i.e., P(S|P) and P(S|T)] (ii) poverty gaps, welfare and freedom of the press directly cause the spread of the virus [i.e., P(S|E), P(S|W), and P(S|R)] (iii) Government effectiveness serves as a parent to poverty gaps and welfare [ i.e., P(E|G) and P(W|G)] and voice and accountability serve as a parent to freedom of the press [i.e., P(R|V)]. For the output, we "dichotomized" regions based on the "share of global infection rate" metric (SGIR) that implicitly accounts for a given region's population, and we find that - out of two hundred and nineteen countries investigated, one hundred and twenty-seven have SGIR ≥ 1%, and the majority (44 out 58 - 75.86%) of Africa countries (as of 12

Indexed as

ContinentsFeatures interactionsLow or high spreadNaïve BayesSARS-CoV-2Share of global infection (SGIR)

Identifiers

PMID35915598
PMCPMC9330361

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.